S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
NYSE:CHAQ

Chardan Healthcare Acquisition 2 Stock Forecast, Price & News

$10.50
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.50
Now: $10.50
$10.65
50-Day Range
$9.90
MA: $10.15
$10.50
52-Week Range
$9.57
Now: $10.50
$11.37
Volume15,616 shs
Average Volume15,061 shs
Market Capitalization$113.19 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Chardan Healthcare Acquisition 2 Corp. intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was founded in 2018 and is based in New York, New York.

MarketRank

Overall MarketRank

0.00 out of 5 stars

Unclassified Sector

100th out of 102 stocks

Holding & Other Investment Offices Industry

82nd out of 82 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone646-465-9000
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$113.19 million
Next Earnings DateN/A
OptionableNot Optionable
$10.50
0.00 (0.00 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHAQ News and Ratings via Email

Sign-up to receive the latest news and ratings for CHAQ and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chardan Healthcare Acquisition 2 (NYSE:CHAQ) Frequently Asked Questions

What stocks does MarketBeat like better than Chardan Healthcare Acquisition 2?

Wall Street analysts have given Chardan Healthcare Acquisition 2 a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Chardan Healthcare Acquisition 2 wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Chardan Healthcare Acquisition 2's key competitors?

Who are Chardan Healthcare Acquisition 2's key executives?

Chardan Healthcare Acquisition 2's management team includes the following people:
  • Dr. Gbolahan Amusa C.F.A., M.D., CFA, Chief Science Officer & Exec. Chairman (Age 47)
  • Mr. Jonas Sven Magnus Grossman, Pres, CEO & Director (Age 47)
  • Mr. George B. Kaufman B.A., CFO, Head of Strategy & Director (Age 46)
  • Mr. Guy Barudin, Chief Operating Officer (Age 60)

What is Chardan Healthcare Acquisition 2's stock symbol?

Chardan Healthcare Acquisition 2 trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHAQ."

How do I buy shares of Chardan Healthcare Acquisition 2?

Shares of CHAQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chardan Healthcare Acquisition 2's stock price today?

One share of CHAQ stock can currently be purchased for approximately $10.50.

How big of a company is Chardan Healthcare Acquisition 2?

Chardan Healthcare Acquisition 2 has a market capitalization of $113.19 million.

What is Chardan Healthcare Acquisition 2's official website?

The official website for Chardan Healthcare Acquisition 2 is www.chardanhealthcarespac.com.

How can I contact Chardan Healthcare Acquisition 2?

Chardan Healthcare Acquisition 2's mailing address is 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004. The company can be reached via phone at 646-465-9000.

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.